» Authors » C I McCormick

C I McCormick

Explore the profile of C I McCormick including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 238
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fortin D, McCormick C, Remsen L, Nixon R, Neuwelt E
Neurosurgery . 2000 Aug; 47(1):199-207. PMID: 10917363
Objective: Osmotic blood-brain barrier disruption (BBBD) increases brain and brain tumor delivery of chemotherapeutic agents, which results in increased efficacy against brain tumors. We previously noted that the use of...
2.
Remsen L, Pagel M, McCormick C, Fiamengo S, Sexton G, Neuwelt E
Anesth Analg . 1999 Mar; 88(3):559-67. PMID: 10072006
Unlabelled: Increasing the delivery of therapeutic drugs to the brain improves outcome for patients with brain tumors. Osmotic opening of the blood-brain barrier (BBB) can markedly increase drug delivery, but...
3.
Neuwelt E, Barnett P, McCormick C, Remsen L, Kroll R, Sexton G
Clin Cancer Res . 1998 Jun; 4(6):1549-55. PMID: 9626476
To assess how to maximize drug delivery to intracerebral tumors and surrounding brain, this study examined the effects of route and method of administration and tumor size on the distribution...
4.
Remsen L, McCormick C, Sexton G, PEARSE H, Garcia R, Mass M, et al.
Neurosurgery . 1997 May; 40(5):1034-40; discussion 1040-2. PMID: 9149262
Objective: The goal was to evaluate, at 1 year, 75 Long-Evans rats for survival rates and toxicity associated with the sequencing of cranial irradiation and enhanced chemotherapy delivery. Methods: Seventy-five...
5.
Remsen L, McCormick C, Nilaver G, Weissleder R, Bogdanov A, Hellstrom I, et al.
AJNR Am J Neuroradiol . 1996 Mar; 17(3):411-8. PMID: 8881233
Purpose: To determine if tumor-specific monoclonal antibodies conjugated to superparamagnetic monocrystalline iron oxide nanoparticles can be used to yield specific diagnoses with the use of MR imaging. Methods: Monoclonal antibodies...
6.
Neuwelt E, BRUMMETT R, Remsen L, Kroll R, Pagel M, McCormick C, et al.
Cancer Res . 1996 Feb; 56(4):706-9. PMID: 8630999
When carboplatin (cis-diammine-1,1-cyclobutane-dicarboxylato-platinum) delivery to brain tumors is optimized with osmotic blood-brain barrier disruption (BBBD), high frequency hearing loss can result. Treatment with sodium thiosulfate (STS) blocked carboplatin cytotoxicity against...
7.
Remsen L, McCormick C, Sexton G, PEARSE H, Garcia R, Neuwelt E
Clin Cancer Res . 1995 Jul; 1(7):731-9. PMID: 9816039
The sequence of chemotherapy administered prior to cranial irradiation rather than the more traditional order of radiation followed by chemotherapy is currently being evaluated. This rodent study was designed to...
8.
Barnett P, Ramsey F, McCormick C, Sexton G, Szumowski J, Neuwelt E
Am J Pathol . 1995 Feb; 146(2):436-49. PMID: 7856753
This study characterized agent differential permeability, three-dimensional tumor volume, and survival in an LX-1 human small cell lung carcinoma intracerebral xenograft model in the nude rat. The percent accessible tissue...
9.
Neuwelt E, Barnett P, Hellstrom K, Hellstrom I, McCormick C, Ramsey F
J Nucl Med . 1994 Nov; 35(11):1831-41. PMID: 7965166
Unlabelled: These studies highlight several factors that affect monoclonal antibody (Mab) localization to a tumor in the brain, including tumor permeability, nonspecific and specific binding, plasma half-life, radiolabeled antibody stability...
10.
Barnett P, McCormick C, Szumowski J, Shannon E, Ramsey F, Mass M, et al.
J Comput Assist Tomogr . 1994 Sep; 18(5):731-6. PMID: 8089321
Objective: This experiment was done to evaluate the gross neurotoxicity of intravenous Gd-DTPA administered in conjunction with osmotic blood-brain barrier (BBB) disruption and to image a human small cell lung...